Anna M. Vold-Hoffmann
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Navigating evidence-based recommendations for the management of systemic sclerosis.
Journal: Nature reviews. Rheumatology
Published: July 16, 2026
High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey.
Journal: Clinical and experimental rheumatology
Published: November 22, 2021
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.
Journal: Rheumatology (Oxford, England)
Published: October 11, 2021
Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders.
Journal: Therapeutic advances in musculoskeletal disease
Published: April 10, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial.
Journal: The Lancet. Respiratory medicine
Published: October 17, 2019
Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease.
Journal: Expert review of clinical immunology
Published: October 01, 2019
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 18, 2018
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 09, 2017
OX40L blockade protects against inflammation-driven fibrosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 15, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026